Best Pharmaceuticals for Children Act Report from the Committee on Energy and Commerce, U.S. House of Representatives

The Committee, to whom was referred the bill (H.R. 2887) to amend the Fed. Food, Drug, & Cosmetic Act to improve the safety & efficacy of pharmaceuticals for children, recommend that the bill as amended to pass. Sections: Amendment; Purpose & Summary; Background & Need for Legis.; Hearings; Committee Consideration; Committee Votes; Committee Oversight Findings; Statement of General Performance Goals & Objectives; New Budget Authority, Entitlement Authority, & Tax Exp.; Committee Cost Est.; CBO Est.; Fed. Mandates State.; Advisory Committee State.; Constitutional Auth. State.; Applicability to Legis. Branch; Section-by-Section Analysis of the Legis.; Changes in Existing Law Made by the Bill; & Dissenting Views.Tauzin, W. J. Billy is the author of 'Best Pharmaceuticals for Children Act Report from the Committee on Energy and Commerce, U.S. House of Representatives' with ISBN 9780756731953 and ISBN 075673195X.